Jianli Ma

1.1k total citations
28 papers, 853 citations indexed

About

Jianli Ma is a scholar working on Pharmaceutical Science, Oncology and Molecular Biology. According to data from OpenAlex, Jianli Ma has authored 28 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Jianli Ma's work include Drug Solubulity and Delivery Systems (7 papers), Advanced Drug Delivery Systems (7 papers) and Nanoparticle-Based Drug Delivery (4 papers). Jianli Ma is often cited by papers focused on Drug Solubulity and Delivery Systems (7 papers), Advanced Drug Delivery Systems (7 papers) and Nanoparticle-Based Drug Delivery (4 papers). Jianli Ma collaborates with scholars based in China, United States and Philippines. Jianli Ma's co-authors include Lei Gao, Xiaoqing Wang, Guiyang Liu, Liang Zhou, Xiang Li, Fang Wang, Lingmin Jiang, Qingzhe Zhang, Wei Pei and Liang Zhou and has published in prestigious journals such as Journal of Controlled Release, Pharmaceutical Research and Colloids and Surfaces A Physicochemical and Engineering Aspects.

In The Last Decade

Jianli Ma

28 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jianli Ma China	13	443	244	208	95	91	28	853
Sunitha Sampathi India	16	315 0.7×	193 0.8×	190 0.9×	62 0.7×	64 0.7×	37	734
Kwan Hyung Cho South Korea	18	377 0.9×	150 0.6×	169 0.8×	96 1.0×	61 0.7×	64	828
Sandip B. Tiwari United States	16	509 1.1×	247 1.0×	241 1.2×	84 0.9×	62 0.7×	20	955
Jae Geun Song South Korea	14	291 0.7×	253 1.0×	301 1.4×	77 0.8×	51 0.6×	26	782
Quanlei Zhu China	12	684 1.5×	323 1.3×	409 2.0×	77 0.8×	98 1.1×	15	1.0k
Rishikesh M. Kulkarni United States	8	502 1.1×	158 0.6×	224 1.1×	110 1.2×	119 1.3×	10	965
Himanshu Agrawal India	13	310 0.7×	269 1.1×	251 1.2×	93 1.0×	53 0.6×	34	919
Mahesh D. Chavanpatil India	9	417 0.9×	318 1.3×	204 1.0×	70 0.7×	117 1.3×	12	877

Countries citing papers authored by Jianli Ma

Since Specialization

Citations

This map shows the geographic impact of Jianli Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianli Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianli Ma more than expected).

Fields of papers citing papers by Jianli Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianli Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianli Ma. The network helps show where Jianli Ma may publish in the future.

Co-authorship network of co-authors of Jianli Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jianli Ma. A scholar is included among the top collaborators of Jianli Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianli Ma. Jianli Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Egan, Regina K., Jianli Ma, Jong Kung, et al.. (2025). Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer Models. Molecular Cancer Therapeutics. 24(6). 920–930. 1 indexed citations

Liu, Hongfang, et al.. (2024). Homologous phospholipid bilayer-modified Pd-based bimetallic nanozymes provide parallel therapy through efficient triple enzyme activity under NIR light excitation. Colloids and Surfaces A Physicochemical and Engineering Aspects. 708. 135959–135959. 2 indexed citations

Ma, Jianli, Yuwei Deng, Dawei Chen, et al.. (2023). Spatial immunophenotypes orchestrate prognosis in triple-negative breast cancer with Miller-Payne grade 4 following neoadjuvant chemotherapy. npj Breast Cancer. 9(1). 57–57. 3 indexed citations

Ma, Jianli, Yuwei Deng, Minghui Zhang, & Jinming Yu. (2022). The role of multi-omics in the diagnosis of COVID-19 and the prediction of new therapeutic targets. Virulence. 13(1). 1101–1110. 11 indexed citations

Ma, Jianli, Minghui Zhang, & Jinming Yu. (2022). Identification and Validation of Immune-Related Long Non-Coding RNA Signature for Predicting Immunotherapeutic Response and Prognosis in NSCLC Patients Treated With Immunotherapy. Frontiers in Oncology. 12. 899925–899925. 6 indexed citations

Ji, Liu, Jianli Ma, & Qingyuan Zhang. (2022). Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer. Frontiers in Genetics. 13. 929870–929870. 2 indexed citations

Chen, Shuaishuai, Xiaojuan Yang, Ziying Wei, et al.. (2021). Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen). Pharmaceutical Biology. 59(1). 535–543. 4 indexed citations

Yang, Pei, et al.. (2021). Effect of cetuximab combined with IMRT and concurrent chemotherapy in treating locally advanced nasopharyngeal carcinoma.. PubMed. 26(1). 138–144. 1 indexed citations

Gao, Yanan, Xing Fan, Nan Li, et al.. (2020). CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma. Pharmacological Research. 157. 104800–104800. 27 indexed citations

10.

Jiang, Yaqin, et al.. (2019). Expression of matrix Metalloproteinases-2 and aquaporin-1 in corneoscleral junction after angle-closure in rabbits. BMC Ophthalmology. 19(1). 43–43. 2 indexed citations

11.

Wang, Xiaoqing, Jianli Ma, Xiaoming Zhu, Fang Wang, & Liang Zhou. (2017). Minocycline-loaded In situ Hydrogel for Periodontitis Treatment. Current Drug Delivery. 15(5). 664–671. 13 indexed citations

12.

Li, Xiang, Min Wang, Guiyang Liu, & Jianli Ma. (2016). Dual VEGF/EGFR inhibition versus single targeted agent treatment in patients with metastatic colorectal cancer: a meta-analysis of randomized trials. International Journal of Colorectal Disease. 31(9). 1655–1656. 5 indexed citations

13.

Li, Xiang, Guiyang Liu, Jianli Ma, & Liang Zhou. (2015). Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis. Clinics. 70(6). 453–459. 21 indexed citations

14.

Li, Xiang, et al.. (2015). Lack of IL-6 increases blood–brain barrier permeability in fungal meningitis. Journal of Biosciences. 40(1). 7–12. 26 indexed citations

15.

Gao, Lei, Guiyang Liu, Jianli Ma, et al.. (2014). Paclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cells. Colloids and Surfaces B Biointerfaces. 117. 122–127. 36 indexed citations

16.

Wang, Xiaoqing, Guiyang Liu, Jianli Ma, et al.. (2013). In Situ Gel-Forming System: An Attractive Alternative for Nasal Drug Delivery. Critical Reviews in Therapeutic Drug Carrier Systems. 30(5). 411–434. 36 indexed citations

17.

Gao, Lei, Guiyang Liu, Jianli Ma, et al.. (2012). Application of Drug Nanocrystal Technologies on Oral Drug Delivery of Poorly Soluble Drugs. Pharmaceutical Research. 30(2). 307–324. 170 indexed citations

18.

Ma, Jianli, et al.. (2012). A randomized trial of chinese medicine lirukang granule (利乳康颗粒) combined with psychological intervention for cyclomastopathy and menoxenia. Chinese Journal of Integrative Medicine. 19(1). 22–28. 3 indexed citations

19.

Jiang, Lingmin, et al.. (2010). The application of mucoadhesive polymers in nasal drug delivery.. PubMed. 36(3). 323–36. 41 indexed citations

20.

Jiang, Lingmin, et al.. (2010). The application of mucoadhesive polymers in nasal drug delivery. Drug Development and Industrial Pharmacy. 36(3). 323–336. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact